Purdue Pharma Seeks Supreme Court Review Amid Patent Dispute and Bankruptcy Struggles

In a significant legal move, Purdue Pharma LP is seeking the intervention of the U.S. Supreme Court in an effort to overturn a decision by the Federal Circuit. The case revolves around Purdue’s attempt to use patent laws to prevent the market entry of a competing “crush-resistant” generic painkiller. Purdue argues that the current ruling by the Federal Circuit applies a “rigid” standard that unfairly threatens the company’s patent protections.

Purdue Pharma is currently addressing bankruptcy issues, and the outcome of this legal challenge could have broad implications for both its financial recovery and the pharmaceutical industry at large. For a detailed account of the ongoing legal proceedings, please refer to the original article on Law360.